Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation
Rick Admiraal(NHS Blood and Transplant), Caroline A. Lindemans(University Medical Center Utrecht), C. Michel Zwaan(Hôpital Saint-Michel), Robbert G. M. Bredius(Leiden University Medical Center), Friso Calkoen(Princess Máxima Center), Elizabeth Klein(Memorial Sloan Kettering Cancer Center), Maria Cancio(Memorial Sloan Kettering Cancer Center), Birgitta Versluijs(Utrecht University), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wouter J.W. Kollen(Princess Máxima Center), Marc Bierings(University Medical Center Utrecht), Andromachi Scaradavou(NewYork–Presbyterian Hospital), Stefan Nierkens(Utrecht University), Jaap Jan Boelens(Wilhelmina Children's Hospital), Mirjam E. Belderbos(Princess Máxima Center), Alwin D. R. Huitema(The Netherlands Cancer Institute)
Cited by 21
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k